Found: 7
Select item for more details and to access through your institution.
Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 3, p. 591, doi. 10.1007/s10549-022-06714-0
- By:
- Publication type:
- Article
Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 1, p. 205, doi. 10.1007/s10549-020-05930-w
- By:
- Publication type:
- Article
Heart failure after treatment for breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics.
- Published in:
- Clinical Epidemiology, 2018, v. 10, p. 1523, doi. 10.2147/CLEP.S161359
- By:
- Publication type:
- Article
Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4285, doi. 10.1002/cncr.34464
- By:
- Publication type:
- Article